Dow and collaborators demonstrated that APC restoration in colon cancer cells could revert the malignant phenotype to functional differentiated intestinal units, thus inducing regression in tumors harboring KRASG12D and TRP53 mutations31. The gene discussed is TP53; the disease is colonic neoplasm.